mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |